North America Chondroitin Sulfate Market Size & Outlook

The chondroitin sulfate market in North America is expected to reach a projected revenue of US$ 535.8 million by 2030. A compound annual growth rate of 3.3% is expected of North America chondroitin sulfate market from 2025 to 2030.
Revenue, 2024 (US$M)
$441.9
Forecast, 2030 (US$M)
$535.8
CAGR, 2025 - 2030
3.3%
Report Coverage
North America

North America chondroitin sulfate market highlights

  • The North America chondroitin sulfate market generated a revenue of USD 441.9 million in 2024.
  • The market is expected to grow at a CAGR of 3.3% from 2025 to 2030.
  • In terms of segment, bovine was the largest revenue generating source in 2024.
  • Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 441.9 million
Market revenue in 2030USD 535.8 million
Growth rate3.3% (CAGR from 2025 to 2030)
Largest segmentBovine
Fastest growing segmentSynthetic
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBovine, Swine, Poultry, Shark, Synthetic
Key market players worldwideMerck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts

Other key industry trends

  • In terms of revenue, North America region accounted for 36.2% of the global chondroitin sulfate market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 385.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Chondroitin Sulfate Market Companies

Name Profile # Employees HQ Website

North America chondroitin sulfate market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.


Bovine was the largest segment with a revenue share of 38.88% in 2024. Horizon Databook has segmented the North America chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.


North America was the largest regional market for chondroitin sulfate, where the growth can be attributed to the booming pharmaceutical industry in the U.S. coupled with the FDA approval for using sodium chondroitin sulfate infused products. In North America, bovine-sourced chondroitin sulfate is preferred owing to easy availability and low cost.

Reasons to subscribe to North America chondroitin sulfate market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America chondroitin sulfate market databook

  • Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America chondroitin sulfate market , including forecasts for subscribers. This continent databook contains high-level insights into North America chondroitin sulfate market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America chondroitin sulfate market size, by country, 2018-2030 (US$M)

North America Chondroitin Sulfate Market Outlook Share, 2024 & 2030 (US$M)

North America chondroitin sulfate market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more